ATE251616T1 - Verfahren zur herstellung von 5- hydroxymethylthiazole - Google Patents

Verfahren zur herstellung von 5- hydroxymethylthiazole

Info

Publication number
ATE251616T1
ATE251616T1 AT98942099T AT98942099T ATE251616T1 AT E251616 T1 ATE251616 T1 AT E251616T1 AT 98942099 T AT98942099 T AT 98942099T AT 98942099 T AT98942099 T AT 98942099T AT E251616 T1 ATE251616 T1 AT E251616T1
Authority
AT
Austria
Prior art keywords
hydroxymethylthiazole
compound
formula
preparation
producing
Prior art date
Application number
AT98942099T
Other languages
English (en)
Inventor
Michael S Allen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE251616T1 publication Critical patent/ATE251616T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98942099T 1997-08-29 1998-08-18 Verfahren zur herstellung von 5- hydroxymethylthiazole ATE251616T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/921,399 US5959118A (en) 1997-08-29 1997-08-29 Process for the preparation of 5-hydroxymethylthiazoles
PCT/US1998/017100 WO1999011636A1 (en) 1997-08-29 1998-08-18 Process for the preparation of 5-hydroxymethylthiazoles

Publications (1)

Publication Number Publication Date
ATE251616T1 true ATE251616T1 (de) 2003-10-15

Family

ID=25445373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942099T ATE251616T1 (de) 1997-08-29 1998-08-18 Verfahren zur herstellung von 5- hydroxymethylthiazole

Country Status (10)

Country Link
US (1) US5959118A (de)
EP (1) EP1007517B1 (de)
JP (1) JP2002510331A (de)
AT (1) ATE251616T1 (de)
CA (1) CA2294089A1 (de)
DE (1) DE69818837T2 (de)
DK (1) DK1007517T3 (de)
ES (1) ES2209198T3 (de)
PT (1) PT1007517E (de)
WO (1) WO1999011636A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1313624B1 (it) 1999-09-21 2002-09-09 Archimica Spa Ora Clariant Lif Procedimento per la sintesi del ritonavir
CN101863853B (zh) * 2009-12-28 2012-12-19 安徽贝克联合制药有限公司 一锅煮法制备5-羟甲基噻唑工艺
BR112020008124A2 (pt) 2017-10-27 2020-10-06 Syngenta Participations Ag composições de controle de vetores, métodos e produtos utilizando as mesmas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299083A (en) * 1967-01-17 Processes for preparing hydroxy- methylthiazole
US2332906A (en) * 1939-10-03 1943-10-26 Foldi Zolten Process for preparation of sulphonamide derivatives
DE3631538A1 (de) * 1986-09-17 1988-03-24 Bayer Ag Verfahren zur herstellung von 2-chlor-5-chlormethylthiazol
US5539122A (en) * 1989-05-23 1996-07-23 Abbott Laboratories Retroviral protease inhibiting compounds
US5354866A (en) * 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
JPH10509177A (ja) * 1994-11-22 1998-09-08 アボツト・ラボラトリーズ 5−ヒドロキシメチルチアゾールの製造方法
DE19520612A1 (de) * 1995-06-06 1996-12-12 Bayer Ag Verfahren zur Herstellung von Benzylalkohol
WO1997010226A1 (en) * 1995-09-11 1997-03-20 Novartis Ag Process for preparing a 2-chloro-5-chloromethyl-thiazole compound
GB9518824D0 (en) * 1995-09-14 1995-11-15 Fine Organics Ltd Preparation of substituted thiazoles
DE19547076A1 (de) * 1995-12-18 1997-06-19 Bayer Ag Verbessertes Verfahren zur Herstellung von 5-Hydroxymethylthiazol
ES2224187T3 (es) * 1995-12-21 2005-03-01 Syngenta Participations Ag Procedimiento para la preparacion de 2-cloro-5-clorometiltiazol.
KR100520249B1 (ko) * 1997-01-22 2005-10-12 신젠타 파티서페이션즈 아게 티아졸 유도체의 제조 방법
US5773625A (en) * 1997-10-02 1998-06-30 Abbott Laboratories Process for the preparation of disubstituted carbonates

Also Published As

Publication number Publication date
ES2209198T3 (es) 2004-06-16
DE69818837T2 (de) 2004-07-22
CA2294089A1 (en) 1999-03-11
DK1007517T3 (da) 2004-02-09
EP1007517B1 (de) 2003-10-08
DE69818837D1 (de) 2003-11-13
WO1999011636A1 (en) 1999-03-11
PT1007517E (pt) 2004-03-31
EP1007517A1 (de) 2000-06-14
US5959118A (en) 1999-09-28
JP2002510331A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
DK1185520T3 (da) Fremgangsmåde til fremstilling af thiazolidin
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
DE69906074D1 (de) Verfahren zur herstellung von 3-aryl-benzofuranonen
DE69818837D1 (de) Verfahren zur herstellung von 5-hydroxymethylthiazole
PT1213279E (pt) Processo para a preparacao de venlafaxina
DE69632919D1 (de) Verfahren zur herstellung von 2-chlor-5-chloromethyl-thiazol
ATE138376T1 (de) Verfahren zur herstellung von benzylphthalazinonderivaten und von deren salzen
DE69604642D1 (de) Verfahren zur herstellung von iodierten kontrastmitteln
DE69936350D1 (de) Verfahren zur herstellung fluorierter benzoesäuren
DE69719450D1 (de) Verfahren zur Herstellung von Arylvinylsulfonen
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE240945T1 (de) Verfahren zur herstellung von 4-((2',5'-diamino- 6'-halogenpyrimidin-4'-yl)amino)-cyclopent-2- enylmethanolen
ATE195115T1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten
DE60110019D1 (de) Verfahren zur Herstellung von Cyclopropancarboxylaten
ATE259785T1 (de) Verfahren zur herstellung von 2-alkylthio- substituierten benzoesäurederivaten
ATE253553T1 (de) Verfahren zur herstellung von 2- alkylthiobenzonitril-derivaten
ATE260883T1 (de) Verfahren zur herstellung von atropasäureethylester
DE60142962D1 (de) Verfahren zur herstellung von pestiziden verbindungen
DE69612237D1 (de) Verfahren zur Herstellung von alpha-Methyl-2-thiophenessigsäure-Derivaten
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
DE69129605D1 (de) Verfahren zur Herstellung von N-Alkylpyrazolen
ES2164345T3 (es) Procedimiento de produccion de compuestos 3-norcefema.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007517

Country of ref document: EP

REN Ceased due to non-payment of the annual fee